Collaboration and progress: How Target Pediatric AML facilitated LLS PedAL – a global master trial in acute leukemia

We were pleased to invite CAC2 members, associate members, student members, supporting organizations to our October CAC2 All-member webinar.  We hosted TpAML co-founder/advocate Julie Guillot and Dr. Gwen Nichols, Chief Medical Officer, Leukemia & Lymphoma Society, who highlighted the energy and work behind putting — and keeping — the patient at the center of drug development.

Thank you for joining us for opportunity to learn valuable insights on the makings of Target Pediatric AML (that a number of CAC2 members worked together on) and how research findings have spurred on the launch of a groundbreaking global master clinical trial initiative in high-risk childhood leukemia, LLS PedAL.



Leave a Comment

Your email address will not be published. Required fields are marked *


Lost your password?